CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB

Main Article Content

LESESVE
a:1:{s:5:"en_US";s:10:"CHRU Nancy";}

Keywords

CART-cells, lymphocyte, morphology, immunophenotyping

Abstract

CAR-T cells are a new possibility for care poor prognostic conditions. CAR-T cells injection lead to T chimeric cells circulation into the blood. Here is reported the cytomorphologic and immunophenotypic features of CAR-T cells in the peripheral blood.

Downloads

Download data is not yet available.


Abstract 891
PDF Downloads 415
HTML Downloads 146

References

1-Labanieh L, Majzner RG, Mackall CL. Programming CAR-T cells to kill cancer. Nat Biomed Eng. 2018;2(6):377-391.
doi: 10.1038/s41551-018-0235-9. Epub 2018 Jun 11.
2-Kersten MJ, Spanjaart AM, Thieblemont C. CD19-directed CAR T-cell therapy in B-cell NHL. Curr Opin Oncol. 2020;32(5):408-417.
doi: 10.1097/CCO.0000000000000668.
3 - Galli E, Bellesi S, Viscovo M, Sorà F, Hohaus S, Piccirillo N, Laurenti N, Chiusolo P, De Stefano V, Sica S, Zini G. Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T). MediterrJ Hematol Infect Dis 2021 ;13;e2021066.
Doi: 10.4084/MJHID.2021.066
4-Yang C, Lei W, Xie H, et al. Sustained Remission of Relapsed or Refractory Mantle Cell Lymphoma After 4-1BB-Based CD19-Directed CAR-T Therapy. Onco Targets Ther. 2020;13:12163-12168.
doi: 10.2147/OTT.S280535. eCollection 2020.
5- Dana H, Chalbatani GM, Jalali SA, Mirzaei HR, Grupp SA, Suarez ER, Rapôso C, Webster TJ. CAR-T cells: Early successes in blood cancer and challenges in solid tumors. Acta Pharm Sin B. 2021 May;11(5):1129-1147.
doi: 10.1016/j.apsb.2020.10.020. Epub 2020 Nov 2.

Article Sidebar

PDF HTML
Published
Feb 27, 2022
DOI https://doi.org/10.4084/MJHID.2022.024

Article Details

How to Cite

LESESVE (2022) “CAR-T cells microscopic and phenotypic identification in the peripheral blood : CAR-T cells in the PB”, Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022024. doi: 10.4084/MJHID.2022.024.
Issue
Vol. 14 No. 1 (2022): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.